PBIRx’s Patricia Sirowich Named to Hartford Business Journal Power 25 in Healthcare

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Identifying leaders who have had a significant impact on healthcare and public health

PBIRx, Inc. is proud to announce that Patricia Sirowich has been named to The Hartford Business Journal Power 25 Healthcare list, which identifies leaders who have had a significant impact on the industry and public health. Sirowich is the founder and president of PBIRx, the premier consultant firm in the pharmacy benefit industry, providing individualized consulting and auditing services for more than 30 years.

“I am pleased to be recognized among these healthcare leaders by The Hartford Business Journal,” said Sirowich. “When I started in this industry in 1987, pharmacy benefits represented 4% of health care dollars. Now, depending on the demographics, it represents up to 40% of health care dollars and is the most utilized and valued benefit to members. Soaring drug costs and growing demands for greater pharmacy benefit manager (PBM) accountability are increasingly driving employers to seek expert guidance. PBIRx delivers average plan savings of 18-22% annually for our client partners.”

PBIRx is a market leader in the pharmacy benefit industry with vast experience working with Fortune 100 companies, large and small employers, unions, hospitals, municipalities, managed health care plans, coalitions, and third-party administrators. In 1993, Sirowich founded PBIRx to combat increased pharmacy costs and the lack of transparency for plan sponsors. Under Sirowich’s leadership, PBIRx provides expertise in all areas of the pharmacy benefit, from identifying specialty drug savings opportunities to advising in contract negotiations. Before founding PBIRx, she was one of the founders of Express Scripts, contributing to the growth of what is now the largest pharmacy benefit management organization in the country.

“As a woman with decades of experience in the pharmacy benefit sector,” said Sirowich, “I bring a wealth of knowledge and am beyond proud of the diverse team of experts, including Doctors of Pharmacy, Clinicians, Analysts, Account Consultants, Support Specialists, IT and Legal, whom I personally interview, hire, and mentor. PBIRx wants intelligent, experienced people, eager to learn on a continuum, who care, are ethical and service oriented, and who respect the importance of each client and their fiduciary responsibilities to their plan and their members. We believe in diving in the weeds, constantly looking for savings solutions based on each client’s culture and needs, all of which has contributed to PBIRx’s success and the success of our client partners.”

About PBIRx
Founded in 1993, PBIRx provides independent pharmacy benefit auditing and consulting to employers and health plans, unraveling the complexities of pharmacy benefit management. Our mission is to create optimal healthcare outcomes while minimizing overall healthcare costs. The firm holds SOC 2 Type 2 and SOC 3 attestation reports and has been recognized on the Inc. 5000 list of fastest-growing companies. More information is available at PBIRx.com.

We believe in diving in the weeds, constantly looking for savings solutions based on each client’s culture and needs, all of which has contributed to PBIRx’s success and the success of our client partners.

Contacts

Media Contact:
Angela Cross
PBIRx Marketing Communications Manager
across@pbirx.com
203-882-1188, ext. 220
203-882-1188, ext. 220

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.70
+3.36 (1.41%)
AAPL  294.38
+5.02 (1.73%)
AMD  540.88
-40.03 (-6.89%)
BAC  58.36
+1.38 (2.42%)
GOOG  357.89
+4.56 (1.29%)
META  612.91
+49.62 (8.81%)
MSFT  384.28
+11.26 (3.02%)
NVDA  197.58
-2.51 (-1.25%)
ORCL  142.50
-4.05 (-2.76%)
TSLA  425.30
+4.70 (1.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.